Stride price target raised to $109 from $94 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Stride (LRN) to $109 from $94 and keeps an Equal Weight rating on the shares. With potential for improving consumer credit and rebounding capital markets in 2025, the firm says it prefers Business and Education Services stocks where it expects accelerating growth not yet reflected in valuation.